| scholarly article | Q13442814 |
| P50 | author | Yi-Hsiang Huang | Q41050730 |
| P2093 | author name string | Chang FY | |
| Lee SD | |||
| Wu JC | |||
| Chiang JH | |||
| Lee PC | |||
| Huo T | |||
| P2860 | cites work | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 |
| Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
| Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 | ||
| Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Q29617957 | ||
| Review article: percutaneous treatment of hepatocellular carcinoma | Q30942931 | ||
| Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection | Q34503100 | ||
| Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection | Q34720013 | ||
| Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre | Q35145073 | ||
| Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials | Q41419107 | ||
| Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre | Q43925378 | ||
| Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy | Q43934737 | ||
| Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test | Q43996294 | ||
| Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. | Q44531436 | ||
| Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. | Q44633897 | ||
| Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization | Q54615028 | ||
| Hepatocellular carcinoma | Q57696098 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1301-1308 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey | |
| P478 | volume | 19 |
| Q43004242 | Is there an ideal prognostic model for hepatocellular carcinoma? |
| Q24186496 | Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma |
| Q24240216 | Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma |
| Q38702256 | Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials |
| Q36521439 | Proton beam therapy for hepatocellular carcinoma with limited treatment options |
| Q34628257 | Transarterial therapies for hepatocellular carcinoma. |
| Q89450474 | Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma |
Search more.